The inhibitory SIGLEC receptor, SIGLEC11, known to be expressed in the pancreas (46), was the most strongly downregulated gene in the pancreas of the recent onset T1D patients, and in earlier studies it has been associated with neuroinflammation (45, 46). This evidence concerns the gene SIGLEC11 and type 1 diabetes mellitus.